Lynsey M. Whilding

1.6k total citations
21 papers, 1.2k citations indexed

About

Lynsey M. Whilding is a scholar working on Oncology, Immunology and Biomedical Engineering. According to data from OpenAlex, Lynsey M. Whilding has authored 21 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Oncology, 14 papers in Immunology and 5 papers in Biomedical Engineering. Recurrent topics in Lynsey M. Whilding's work include CAR-T cell therapy research (17 papers), Immunotherapy and Immune Responses (8 papers) and Immune Cell Function and Interaction (7 papers). Lynsey M. Whilding is often cited by papers focused on CAR-T cell therapy research (17 papers), Immunotherapy and Immune Responses (8 papers) and Immune Cell Function and Interaction (7 papers). Lynsey M. Whilding collaborates with scholars based in United Kingdom, United States and Australia. Lynsey M. Whilding's co-authors include John Maher, Ana C. Parente‐Pereira, Sadaf Ghaem‐Maghami, David M. Davies, Tomasz Zabinski, Andrew J.T. George, Leena Halim, Benjamin Draper, Ru Zhou and Pinku Mukherjee and has published in prestigious journals such as Journal of Clinical Oncology, The Journal of Immunology and Cancer Research.

In The Last Decade

Lynsey M. Whilding

21 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lynsey M. Whilding United Kingdom 16 913 571 312 295 236 21 1.2k
Connie P.M. Duong United States 15 1.1k 1.2× 683 1.2× 259 0.8× 379 1.3× 313 1.3× 24 1.4k
Andrew D. Fesnak United States 9 886 1.0× 517 0.9× 385 1.2× 396 1.3× 219 0.9× 20 1.2k
Ana C. Parente‐Pereira United Kingdom 14 812 0.9× 453 0.8× 391 1.3× 258 0.9× 216 0.9× 18 1.1k
Tessa Gargett Australia 19 950 1.0× 592 1.0× 364 1.2× 454 1.5× 261 1.1× 32 1.4k
Bruno L. Cadilha Germany 10 945 1.0× 560 1.0× 277 0.9× 393 1.3× 183 0.8× 16 1.3k
Zongliang Zhang China 16 748 0.8× 468 0.8× 225 0.7× 350 1.2× 255 1.1× 53 1.2k
Elizabeth L. Siegler United States 14 910 1.0× 398 0.7× 444 1.4× 346 1.2× 198 0.8× 37 1.2k
Biagio De Angelis Italy 22 1.2k 1.3× 774 1.4× 326 1.0× 543 1.8× 352 1.5× 44 1.7k
Mark B. Geyer United States 17 814 0.9× 353 0.6× 149 0.5× 613 2.1× 229 1.0× 61 1.6k

Countries citing papers authored by Lynsey M. Whilding

Since Specialization
Citations

This map shows the geographic impact of Lynsey M. Whilding's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lynsey M. Whilding with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lynsey M. Whilding more than expected).

Fields of papers citing papers by Lynsey M. Whilding

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lynsey M. Whilding. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lynsey M. Whilding. The network helps show where Lynsey M. Whilding may publish in the future.

Co-authorship network of co-authors of Lynsey M. Whilding

This figure shows the co-authorship network connecting the top 25 collaborators of Lynsey M. Whilding. A scholar is included among the top collaborators of Lynsey M. Whilding based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lynsey M. Whilding. Lynsey M. Whilding is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Barnard, Alun R., Lynsey M. Whilding, Zara Hannoun, et al.. (2025). Efficient in vivo generation of CAR T cells using a retargeted fourth-generation lentiviral vector. Molecular Therapy. 33(10). 4953–4967. 4 indexed citations
2.
Davies, David M., et al.. (2024). Engineering a Dual Specificity γδ T-Cell Receptor for Cancer Immunotherapy. Biology. 13(3). 196–196. 2 indexed citations
3.
Parente‐Pereira, Ana C., Richard Beatson, David M. Davies, et al.. (2022). Generation and application of TGFβ-educated human Vγ9Vδ2 T cells. STAR Protocols. 3(2). 101319–101319. 3 indexed citations
4.
Larcombe-Young, Daniel, et al.. (2022). Generation of human parallel chimeric antigen receptor (pCAR) T cells to achieve synergistic T cell co-stimulation. STAR Protocols. 3(2). 101414–101414. 3 indexed citations
5.
Zhou, Ru, Mahboubeh Yazdanifar, Lopamudra Das Roy, et al.. (2019). CAR T Cells Targeting the Tumor MUC1 Glycoprotein Reduce Triple-Negative Breast Cancer Growth. Frontiers in Immunology. 10. 1149–1149. 154 indexed citations
6.
Whilding, Lynsey M., Leena Halim, Benjamin Draper, et al.. (2019). CAR T-Cells Targeting the Integrin αvβ6 and Co-Expressing the Chemokine Receptor CXCR2 Demonstrate Enhanced Homing and Efficacy against Several Solid Malignancies. Cancers. 11(5). 674–674. 166 indexed citations
7.
Natoli, Marina, Lynsey M. Whilding, Ana C. Parente‐Pereira, et al.. (2018). Chemotherapy-induced apoptosis, autophagy and cell cycle arrest are key drivers of synergy in chemo-immunotherapy of epithelial ovarian cancer. Cancer Immunology Immunotherapy. 67(11). 1753–1765. 29 indexed citations
8.
Papa, Sophie, Antonella Adami, Daniela Achkova, et al.. (2018). A phase I trial of T4 CAR T-cell immunotherapy in head and neck squamous cancer (HNSCC).. Journal of Clinical Oncology. 36(15_suppl). 3046–3046. 38 indexed citations
9.
Petrovic, Roseanna M., Daniela Achkova, Tomasz Zabinski, et al.. (2017). CAR T-cell immunotherapy of MET-expressing malignant mesothelioma. OncoImmunology. 6(12). e1363137–e1363137. 52 indexed citations
10.
Papa, Sophie, Antonella Adami, Daniela Achkova, et al.. (2017). Abstract CT118: T4 immunotherapy of head and neck squamous cell carcinoma using pan-ErbB targeted CAR T-cells. Cancer Research. 77(13_Supplement). CT118–CT118. 5 indexed citations
11.
Whilding, Lynsey M., Ana C. Parente‐Pereira, Tomasz Zabinski, et al.. (2017). Targeting of Aberrant αvβ6 Integrin Expression in Solid Tumors Using Chimeric Antigen Receptor-Engineered T Cells. Molecular Therapy. 25(1). 259–273. 69 indexed citations
12.
Chatterjee, Jayanta, Wei Dai, Nor Haslinda Abd Aziz, et al.. (2016). Clinical Use of Programmed Cell Death-1 and Its Ligand Expression as Discriminatory and Predictive Markers in Ovarian Cancer. Clinical Cancer Research. 23(13). 3453–3460. 47 indexed citations
13.
Whilding, Lynsey M., Sabari Vallath, & John Maher. (2016). The integrin αvβ6: a novel target for CAR T-cell immunotherapy?. Biochemical Society Transactions. 44(2). 349–355. 22 indexed citations
14.
Whilding, Lynsey M. & John Maher. (2015). CAR T‐cell immunotherapy: The path from the by‐road to the freeway?. Molecular Oncology. 9(10). 1994–2018. 43 indexed citations
15.
Whilding, Lynsey M. & John Maher. (2015). ErbB-targeted CAR T-cell Immunotherapy of Cancer. Immunotherapy. 7(3). 229–241. 26 indexed citations
16.
Teo, Pei Y., Chuan Yang, Lynsey M. Whilding, et al.. (2015). Ovarian Cancer Immunotherapy Using PD‐L1 siRNA Targeted Delivery from Folic Acid‐Functionalized Polyethylenimine: Strategies to Enhance T Cell Killing. Advanced Healthcare Materials. 4(8). 1180–1189. 145 indexed citations
17.
Parente‐Pereira, Ana C., Hilary Shmeeda, Lynsey M. Whilding, et al.. (2014). Adoptive Immunotherapy of Epithelial Ovarian Cancer with Vγ9Vδ2 T Cells, Potentiated by Liposomal Alendronic Acid. The Journal of Immunology. 193(11). 5557–5566. 47 indexed citations
18.
Maine, Christian J., Nor Haslinda Abd Aziz, Jayanta Chatterjee, et al.. (2013). Programmed death ligand-1 over-expression correlates with malignancy and contributes to immune regulation in ovarian cancer. Cancer Immunology Immunotherapy. 63(3). 215–224. 100 indexed citations
19.
Whilding, Lynsey M., et al.. (2013). Vaccinia Virus Induces Programmed Necrosis in Ovarian Cancer Cells. Molecular Therapy. 21(11). 2074–2086. 55 indexed citations
20.
Stegen, Sjoukje J. C. van der, David M. Davies, Scott Wilkie, et al.. (2013). Preclinical In Vivo Modeling of Cytokine Release Syndrome Induced by ErbB-Retargeted Human T Cells: Identifying a Window of Therapeutic Opportunity?. The Journal of Immunology. 191(9). 4589–4598. 100 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Connie P.M. Duong Breakdown of academic impact, for papers by Andrew D. Fesnak Breakdown of academic impact, for papers by Ana C. Parente‐Pereira Breakdown of academic impact, for papers by Tessa Gargett Breakdown of academic impact, for papers by Bruno L. Cadilha Breakdown of academic impact, for papers by Zongliang Zhang Breakdown of academic impact, for papers by Elizabeth L. Siegler Breakdown of academic impact, for papers by Biagio De Angelis Breakdown of academic impact, for papers by Mark B. Geyer
Rankless by CCL
2026